ANFIELD CAPITAL MANAGEMENT, LLC CRISPR Therapeutics AG Transaction History

ANFIELD CAPITAL MANAGEMENT, LLC portfolio value:

$26,000
portfolio value

ANFIELD CAPITAL MANAGEMENT, LLC quarter portfolio value change:

+7.54%
quarter

CRISPR Therapeutics AG 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +4.83% 18 shares 3K $65.35 391
Q2 2022 share Increase +23.92% 72 shares 4K $60.77 373
Q1 2022 share 0.00% 0 shares 0 $62.77 136
Q4 2021 share Increase +1136.36% 125 shares 9K $78.85 136
Q3 2021 share Increase 0.00% 11 shares 1K $111.93 11